In the current case, NGS studies showed the presence of EGFR-V323I mutation in the original mature cystic teratoma, while revealing BRIP1 rearrangement, CRKL amplification, MAPK1 amplification, and TP53 loss in the secondary angiosarcoma. The gene discussed is EGFR; the disease is cystic teratoma.